Author

Ana Cristina Hernandez Daly

Observed names: A. C. Hernandez Daly, A.C. Hernandez Daly, A.C. Hernandez-Daly, Ana C. Hernandez Daly, Ana C Hernandez Daly

Institution: Boehringer Ingelheim (Germany)

Observed institutions: Boehringer Ingelheim (Germany), Pfizer (United States)

ORCID: 0000-0001-5013-7281

Observed ORCID: 0000-0001-5013-7281

OpenAlex ID: A5046581853

Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial

2024 · Afsaneh Alavi, Errol P Prens, et al. · British Journal of Dermatology · 44

PDF

Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line

2021 · Bruce Strober, Joyce Leman, et al. · Dermatology and Therapy · 30

PDF

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

2023 · Gerd Horneff, Kirsten Minden, et al. · Pediatric Rheumatology · 20

PDF

Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden

2025 · J. R. Ingram, A. V. Marzano, et al. · Journal of the European Academy of Dermatology and Venereology · 18

Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search

2024 · Lluís Puig, Hideki Fujita, et al. · Dermatology and Therapy · 14

43019 Spesolimab for hidradenitis suppurativa: A proof-of-concept study

2023 · Afsaneh Alavi, Errol Prens, et al. · Journal of the American Academy of Dermatology · 10

PDF

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study

2019 · Dimitrios T. Boumpas, Prodromos Sidiropoulos, et al. · Health and Quality of Life Outcomes · 6

PDF

52676 Safety and efficacy over one year of spesolimab treatment in patients with hidradenitis suppurativa (HS): Interim analysis of an open-label extension (OLE) study

2024 · Alexa B. Kimball, Asfaneh Alavi, et al. · Journal of the American Academy of Dermatology · 2

PDF

PCR234 Impact of Draining Tunnels on Patient- and Physician-Reported Burden in Patients with Hidradenitis Suppurativa (HS)

2023 · J. Kirby, I. Hamzavi, et al. · Value in Health · 2

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

2022 · Dimitris Rigopoulos, Aikaterini Patsatsi, et al. · Dermatology Reports · 1

PDF

Pbi81 Persistence and Healthcare Resource Use (hcru) in Patients Initiating Etanercept Treatment for Ankylosing Spondylitis (as) or Psoriatic Arthritis (psa) in Germany: a Real-world Analysis

2019 · X. Baraliakos, D. Poddubnyy, et al. · Value in Health · 1

Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview Study

2025 · Mark Lebwohl, Hideki Fujita, et al. · Journal of Psoriasis and Psoriatic Arthritis

PDF

64499 Design of Lunsayil, an Adaptive Phase 2b/Phase 3 Clinical trial of Spesolimab in Patients With Moderate-to-Severe Hidradenitis Suppurativa

2025 · Afsaneh Alavi, Falk G. Bechara, et al. · Journal of the American Academy of Dermatology

64392 Patient and Dermatologists Perspectives on Hidradenitis Suppurativa Draining Tunnel Treatment and Unmet Needs

2025 · Antonio Martorell, Steven D. Daveluy, et al. · Journal of the American Academy of Dermatology

64454 Symptom burden and quality of life in patients with generalized pustular psoriasis: Results from a cross-sectional study

2025 · Mark G. Lebwohl, Kilian Eyerich, et al. · Journal of the American Academy of Dermatology

Inclusion of the Patient Voice in Developing Holistic Treatment Goals for Rare Skin Diseases

2025 · Emmylou Casanova, Yuzlina Binti Che Yaacob, et al. · SKIN The Journal of Cutaneous Medicine

Impact of GPP on Quality of Life and Psychological Well-being: Results from a Non-interventional Survey/Interview-based Study

2025 · Mark G. Lebwohl, Kilian Eyerich, et al. · SKIN The Journal of Cutaneous Medicine

52665 The burden of Netherton syndrome and interest in biologics: A qualitative summary of patient and caregiver interview responses

2024 · Amy Paller, Emma Guttman Yassky, et al. · Journal of the American Academy of Dermatology

PDF

P11 Etanercept persistence in juvenile idiopathic arthritis up to adult care in patients in Germany: a real-world analysis

2019 · Kirsten Minden, Gerd Horneff, et al. · Lara D. Veeken

Works count: 19

Citation count: 147

H-index: 6

I10-index: 6